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of Niosomal Emulsions as Novel 
Drug Delivery Vehicle Derived 
from Natural Seaweeds
Reshma Joy, Franklin John and Jinu George
Abstract
Biomedical field uses polysaccharides for the last one half of the century due to 
its remarkable applications. Nature is an abundant source for natural polysaccha-
rides made its use widely in this field. In this present chapter study, the potential of 
alginate-κ-carrageenan and alginate-gelatin hydrogel beads for encapsulating cur-
cumin was investigated. The evaluation of different combination of combinations 
of alginate/κ-carrageenan and alginate/gelatin hydrogel beads were developed and 
drug release properties were compared using curcumin as a model drug. Alginate/ 
κ-carrageenan hydrogel beads with 50:50 weight ratio exhibited higher swelling and 
better drug release percentage than compared to other beads. Antibacterial activity 
of curcumin released from hydrogel beads against B. cereus was established by disc 
assay. This nanosized vehicles with increases the efficacy and to control the delivery 
of biologically active substances at their specific site is as important as the drug 
activity itself.
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1. Introduction
Revolution changes and modifies the conservative systems existing in the entire 
zones of the world. Medicinal chemistry and nanotechnology in that sense practices 
a revolutionary idea that promises healthy life to every human being. One such 
important category belongs to drug delivery is the use of natural sources as drug 
carriers [1]. A number of therapeutic agents show potentiality against cancer, HIV, 
Tuberculosis, and other kind of diseases, but most of them are not having the poten-
tial to overcome the biological barriers inside the body and this causing least effect 
than actual [2]. This appeal the production of a new system that can able to reduce 
the typical hitches associated with drugs. We need safe, secure and efficient mea-
sures to dose new generation diseases that threatening the life of living beings [3].
Accordingly, among the new discovered diseases, cancer leads as a number one 
killer disease because of the versatile nature and failure of therapeutic potential 
against the disease [4]. Recent years witnessed discovery of efficient therapeutic 
agents but its actual challenge is to overcome the biological barriers inside the body 
[5]. Most of the drugs are potent to the particular disease but the properties limited 
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due to its hydrophobic nature, non-specificity, toxicity to normal cells, less stability, 
etc. [6]. So the researchers move to deliver these available potent drugs to the patho-
logical site by diminishing all these factors through entrapment in a biocompatible 
polymers as carriers [7]. They were trying to develop smart drug carriers to enhance 
the efficiency of drugs at its specific site with controlled delivery [8].
Drug delivery is a term that refers the successful delivery of therapeutic agents 
at the specific site with specific time without any kind of degradation [9]. The 
problem associated with available drugs in the market includes hydrophobic nature, 
higher toxic nature, nonspecific release, in vivo degradation and short circulating 
half-lives [10]. Drug delivery systems emerging from the significance of controlled 
release of therapeutic agent on the affected part in the effective time with least 
side effects [1, 11]. Natural polymer based drug carriers is the central focus due to 
biocompatible nature, nontoxicity, low cost, ease of use and biodegradability [10]. 
Specificity [12] of drug molecule can be improved using ligands at the surface of 
delivery systems which in turn termed targeted drug delivery to the affected area 
of  the body [13]. Targeting can be through either passive or active [14]. Major types 
of drug carriers falling under
• Niosomes,
• Liposomes,
• Polymeric micelles,
• Microspheres,
• Nanostructures,
• Nanofibers,
• Protein-DNA complexes,
• Protein-drug conjugates,
• Erythrocytes,
• Virosomes,
• Dendrimers.
Utilization of drug delivery systems is a promising methodology for creating 
efficient therapeutic agents. Among these kinds of carrier’s polymeric micelles, 
dendrimers, liposomes [15] are the growing area because of their outstanding 
properties and smart drug delivery potential [16]. Polymer based systems must 
meet some important features to become a good delivery vehicle such as; the 
backbone should be biocompatible; the term biocompatible in the sense explains 
capacity of a polymer to act with proper host reaction as well as the polymers are 
biodegradable without the formation of any kind of harmful by-products inside the 
body [17–19]. The polymer must soluble in various solvents and versatile in chemi-
cal, structural and in application, etc. [3, 9]. The exploitation of micelles prepared 
from amphiphilic copolymers for solubilization of ineffectively solvent medica-
tions has drawn in much consideration. Natural polysaccharide gets much attention 
towards the preparation of drug delivery systems because of their exceptional 
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hydrogel forming ability [20]. These are derived from plants, sea weeds shells of 
crustaceans and microorganisms [21].
Niosomes are one of the excellent drug carriers, composed of non-ionic surface 
in addition to cholesterol or its derivatives. Niosomes can overcome the disadvan-
tages of the liposomes [22, 23]. Liposomes firstly proposed by Alec Bangham called 
Bangosomes in 1965, the first generation liposomes the entrapped drugs are leaked 
out because of the membranes are not much stronger. In the case of niosomes, the 
hydrophilic and hydrophobic parts influence the entrapment of drug molecules, 
where as in the liposomes, lipophilic domain influences in it [5, 24, 25]. Non-ionic 
surfactants Tween, Brij, Span, etc. are mostly used for the noisome preparation. 
Hydrophilic-lipophilic balance (HLB) is a dimensionless parameter which can 
direct the entrapment efficiency for the drug and controlled release [26]. These 
values are varies between the non-ionic surfactant nature [27–30]. Surfactants with 
a HLB number between 3 and 8 are compatible with preparation bilayer surfaces 
and refer to water-in-oil (W/O) emulsifier [2, 31]. The additives in the niosomes 
include cholesterol and charge inducer. The cholesterol reduces the HLB value and 
charge inducer like dicetyl phosphate (DCP), produce surface charge leads to the 
stabilization of the bilayer [32, 33]. Applications of niosomes mainly related to the 
systemic delivery of hydrophobic drug molecules. More clearly niosome is used to 
improve the stability and physical properties, controlled release of drug molecules 
and for targeting and retention of drug in blood circulation. Niosomes offer various 
advantages over other drug delivery devices and have found applicability in phar-
maceutical field. Niosomes are exceptionally powerful drug delivery instruments 
for construction/focusing of different remedially dynamic moieties and the respon-
sibility lies on future researchers to viably outfit its potential in assorted application 
zones to support humanity [34].
Hydrophilic interpenetrating polymeric networks like hydrogels represent excel-
lent carrier for hydrophobic drug encapsulation. In comparison to hydrophilic nano 
systems widely used in drug delivery, hydrogels show better swelling property and 
biocompatibility [35, 36]. Hydrogels derived from natural polymers like polysac-
charides, alginates, gelatin polysaccharide conjugates exhibit a gradual change 
in swelling properties upon variation in temperature, pH, and ionic strength. 3D 
polymeric network derived from hydrogels represent flexible tissue-like material 
for efficient delivery of hydrophobic drugs [37] (Figure 1).
2. Natural polysaccharides
The use of nanotechnology for the delivery of therapeutic agents was put 
forward by Paul Enrich [6], the proponent of drug loaded magic bullets. Biomedical 
field uses polysaccharides for the last one half of the century due to its remarkable 
applications [38]. Nature is an abundant source for natural polysaccharides made 
its use widely in this field. Most of the drugs used for different types of diseases 
Figure 1. 
(A) Niosome, (B) liposome, (C) polymeric micelles and (D) dendrimers.
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cause dangerous side effects. These problems can be reduced by the use of natural 
biocompatible polymer/polysaccharides as carriers for the drug. Seaweeds provide 
a better source for available polysaccharides such as carrageenan (iota, kappa, and 
lambda), alginate, and agar [39].
Monosaccharides combine to form polysaccharides with number of reactive 
groups that can be easily modified to get various types of polysaccharides. Typical 
sources of polysaccharide include algae, microorganisms, animals, etc. The positive 
features of polysaccharides such as higher molecular weight, changing chemical 
composition and large number of reactive groups gave diversity in its function. 
Adaptable chemical composition delivers its variety in structure and also in prop-
erty. Medicinal field exploits these best properties of polysaccharides for the better-
ment of drug delivery. Drug carriers from polysaccharides make sustainable, cost 
effective and biodegradable drug carriers. Modification of polysaccharide chains 
opens a way to target drug to the affected site, altering the solubility, biocompatibil-
ity, moisture resistant and particularly reduce the severe side effects from therapeu-
tic agents. Polysaccharides can perform bio adhesion through hydrophilic groups 
such as carboxyl, hydroxyl and amino groups by making non covalent interaction 
with biological tissues that elongates residing time. By this the absorption of drug at 
the particular area can be easily made. In this chapter we discuss niosomal emul-
sions of alginate, κ-carrageenan and gelatin as drug carrier [38, 40, 41].
Alginates are naturally derived polysaccharide block copolymers composed 
of β-d-mannuronic acid monomers (M-blocks), α-l-guluronic acids (G-blocks) 
and regions of interspersed M and G units [38, 42]. Divalent cations such as Ca2+ 
can induce hydrogel formation by polysaccharide chain association in alginates 
[20]. Carrageenans represent a family of sulphated linear polysaccharides consist-
ing of (1 → 3)-linked β-galactose and (1 → 4)-linked α-d-galactose units mainly 
extracted from certain red seaweeds of Rhodophyceae family particularly from 
Chondrus crispus, Eucheuma gigartina, Stellate iridaea, Hypnea, Solieria agardhiella 
and Sarconema, which are variously substituted and modified to the 3,6-anhydro 
derivative, depending on the nature of origin and extraction conditions [43]. Three 
main types of carrageenans are known: kappa-κ, lambda-λ and iota-i, depending on 
the number and the position of the ionic sulphate groups. The presence of a suitable 
cation, typically potassium, or calcium is an absolute requirement for gelation of 
the carrageenans, especially kappa [44]. Gelatin is a protein derived from denatured 
collagen that contains high levels of hydroxyproline, proline and glycine. It is useful 
as a thermally reversible gelling agent for encapsulation [45].
However, we go through the development and characterization of alginate/κ-
carrageenan and alginate/gelatin hydrogel beads and its application in encapsula-
tion of a model hydrophobic potential drug, curcumin. Hydrogel beads were 
developed via ionotropic gelation. Alginate/κ-carrageenan beads were cross-linked 
with CaCl2-KCl salt solution and alginate/gelatin beads with CaCl2 solution. Drug 
release behaviour of alginate/κ-carrageenan and alginate/gelatin hydrogel beads was 
compared employing curcumin, which is a natural polyphenolic compound isolated 
from rhizome of turmeric (Curcuma longa) as a model drug [46]. Curcumin is 
widely known to possess antioxidant [47], antitumor [48], and anti-inflammatory 
[49] activity. Swelling of the beads and in vitro release of curcumin were studied in 
phosphate buffered saline (PBS, pH 7.4).
3. Materials and methods
Sodium alginate (RM 7494), κ-carrageenan (22,048, Sigma Aldrich), Gelatin, 
phosphate buffer saline pH 7.4 (PBS, Sigma Aldrich) and curcumin (C1386, Sigma 
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Aldrich) were used without further purification. CaCl2 and KCl were commercial 
products of analytical grade. Single distilled water (Labsil Water Distiller, Model: 
OPTI-M4) was used in all experiments.
3.1 Preparation of alginate/κ-carrageenan and alginate/gelatin hydrogel beads 
and curcumin loading
Alginate, κ-carrageenan and gelatin solutions were prepared separately by 
dissolving each of the biopolymers in distilled water and heated up at 50°C 
(for alginate), 60°C (for κ-carrageenan) and 40°C (for gelatin) under constant 
stirring from 30 min to 1 h until complete dissolution [50]. Ionotropic method 
was used for the preparation of hydrogel beads. Polysaccharide mixture com-
posed of 50:50, 70:30, 80:20 (weight ratio) with concentrations varying from 
1 to 2.5% (given in Table 1) were prepared by mixing under constant stirring 
at 30°C for 30 min. Briefly the hydrogel beads were prepared by dropping the 
mixture through a plastic syringe (5 ml) into an aqueous salt solutions stirred 
magnetically. For the preparation of alginate/κ-carrageenan hydrogel beads, 
the salt solution was composed of 100 ml of 2% (w/v) KCl and 100 ml of 2% 
(w/v) CaCl2 and for alginate/gelatin hydrogel beads, 200 ml of 2% CaCl2 solu-
tion. To complete gelation, beads were maintained in the solution for 30 min 
then filtered, followed by washing with distilled water and then allowed to dry 
overnight at 37°C.
For curcumin loading, 10 mg/ml curcumin prepared with ethanol was mixed 
with each of the alginate/κ-carrageenan and alginate/gelatin mixtures and stirred 
until complete evaporation of ethanol. Curcumin loaded beads were prepared by 
dropping the mixture through a 5 ml syringe into a stirred salt solution which was 
composed of 100 ml of 2% (w/v) KCl and 100 ml of 2% (w/v) CaCl2 in the case of 
alginate/κ-carrageenan and 200 ml of 2% (w/v) CaCl2 for alginate/gelatin and kept 
in the solution for 30 min, filtered, washed with distilled water and dried overnight 
at 37°C.
3.2 Morphological analysis
Scanning electron microscopy (SEM, LEO 1430 V) was used to analyse the 
morphology of hydrogel beads.
3.3 Swelling behaviour
The swelling degree (SD) was determined gravimetrically as follows: Both the 
hydrogel beads were immersed in phosphate buffered saline (PBS, pH 7.4) at 37° 
Materials Weight 
ratio (w/w)
Polymeric 
concentrations (%)
Salt type Salt concentration 
(%) (w/v)
Alginate/κ-carrageenan 50:50
70:30
80:20
1
1.5
2
2.5
CaCl2·KCl 2
Alginate/gelatin 50:50
70:30
80:20
1
1.5
2
2.5
CaCl2 2
Table 1. 
Weight ratio percentage concentrations of polymeric solutions.
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C. The swelled samples were taken from the PBS at selected time intervals of 1, 2, 3, 
4, and 10 up to 24 h, wiped with tissue paper, weighed and placed again in PBS. The 
SD, in percentage, was calculated using Eq. (1)
  SD =  Ws − Wd _______
Wd
 ∗ 100  (%) (1)
where Ws and Wd are the weights of swollen and dry beads, respectively.
3.4 Release study of curcumin
The cumulative release of curcumin from hydrogel beads was carried out 
through incubating samples while shaking at 100 rpm in 20 ml of buffer solution 
(PBS) at pH 7.4 (1, 2, 3, 4, 10 up to 24 h incubation) at 37°C. After incubation, 3 ml 
sample was taken out from the buffer solution and analysed by UV-Vis spectropho-
tometer (Lambda 25-PerkinElmer UV-vis spectrophotometer) at 𝜆max of 430 nm. 
The withdrawn volume of the sample was replaced with equal volume of fresh 
buffer solution to keep the volume of release fluid constant. The percentage drug 
release was calculated by using the following formula,
 Percentage drug release =  (Amount of drug released / 
    Amount of drug loaded) ∗ 100 (2)
4. Results and discussion
4.1 Morphological analysis of hydrogel beads
Image of the swollen beads is shown in Figures 2 and 3. Beads obtained has 
diameter of 0.50 cm. Morphological features of curcumin loaded and unloaded 
beads were analysed through SEM images shown in Figure 4.
The morphological features of curcumin loaded and unloaded beads were 
analysed by recording the SEM images as shown in Figure 4.
Hydrogel beads containing alginate were smoother and more spherical com-
pared to the beads consisting of alginate and carrageenan. This effect can be 
attributed to the higher cross linking ability of alginate relative to carrageenan. This 
cross linking takes place instantaneously upon dropping sodium alginate into the 
cross linking solution (consisting of Ca2+) leading to geometrically stable particles.
In the case of formulations containing carrageenan, the beads were less spheri-
cal, having rough and folded surfaces. This behaviour could be attributed to the low 
concentration of K+ in the hardening solution, and also to the reduced cross-linking 
efficiency of carrageenan as compared to alginate, which led to the production of 
non-spherical and less physically stable beads. The alginate-gelatin hydrogel beads 
show a smooth and homogeneous morphology, suggesting component miscibility 
and blend homogeny.
4.2 Swelling degree
4.2.1 Effect of alginate, κ-carrageenan and gelatin ratios on swelling
In the case of alginate-gelatin and alginate/κ-carrageenan hydrogel beads, 
the effect of sodium alginate on swelling of the hydrogel beads has been studied 
by varying its amount in the polymer blend in the range 50–80% (w/w). The 
results shown in Figures 5 and 6, clearly indicates that initially at 50% of alginate 
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content in the hydrogel beads, the swelling ratio is high, while beyond this amount 
(70–80%) a fall in swelling degree is observed. The observed initial increase in the 
swelling degree could be attributed to the fact that since alginate is a linear anionic 
hydrophilic polymer, its increasing amount in the hydrogel beads cause an increased 
hydrophilicity of the polymer network with fixed ionic charges and enhanced 
repulsion among the polymer chains. This leads to greater swelling. However the 
decrease in swelling degree observed beyond 50% can be attributed to the fact that 
increase in alginate content results in a compact polymer network. This will form 
small pore sizes that slow down the diffusion of water molecules into the hydrogel 
beads and consequently the swelling degree decreases.
The effect of gelatin on the swelling degree of the alginate/gelatin hydrogel 
beads has been studied by varying the amount of gelatin in the polymer blend in 
the range 20–50% (w/w). Figure 5 clearly indicates that, an increase in swelling 
Figure 2. 
Preparation of hydrogel beads and drug loading.
Figure 3. 
Image of the swollen beads.
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degree is observed with increase in gelatin content. An increase in the amount of 
gelatin in hydrogel beads enhances the hydrophilicity of polymer network and 
leads to higher swelling degree. The effect of κ-carrageenan on swelling degree of 
Figure 4. 
SEM micrographs of unloaded (A) alginate/κ-Car, (B) alginate/gelatin hydrogel beads and curcumin loaded, 
(C) alginate/κ-Car, (D) alginate/gelatin hydrogel beads.
Figure 5. 
Effect of alginate/gelatin weight ratio’s on the swelling of the alginate/gelatin composite hydrogel beads at 
different polymer concentrations (a) 1%, (b) 1.5%, (c) 2%, (d) 2.5%.
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alginate/κ-carrageenan hydrogel beads has been studied by varying the amount 
of κ-carrageenan in the range 20–50% (w/w). The results showed in Figure 6 
shows the swelling degree of alginate/κ-carrageenan hydrogel beads increases 
with increase in carrageenan content. With increase in carrageenan content, the 
beads become less compact in structure and large pores and surface cavities were 
observed in the hydrogel beads. The alginate/κ-carrageenan (50:50) hydrogel 
beads show a higher degree of swelling than the alginate/gelatin (50:50) hydrogel 
beads. Swelling behaviour of hydrogel beads were examined by varying polymer 
concentration (1, 1.5, 2, 2.5%). As shown in Figures 5 and 6, increase in polymer 
concentration leads to enhancement in the swelling degree of both hydrogel 
beads. In both cases, hydrogel beads with polymer concentration 2.5% show the 
highest swelling. Comparison of the swelling degree of alginate/κ-carrageenan 
hydrogel beads with alginate/gelatin hydrogel beads shows that the former one 
with polymer concentration 2.5% and weight ratio 50:50 has higher degree of 
swelling than latter alginate/gelatin hydrogel beads with polymer concentration 
2.5% and weight ratio 50:50.
4.3 Curcumin release study
4.3.1 Effect of alginate on curcumin release
Curcumin release studies were carried out in PBS (pH 7.4). Upon variation of 
sodium alginate ratio in the range 50–80% (w/w) in the polymer blend, the amount 
of curcumin released was found to diminish with time. This observation could be 
explained on the basis of swelling behaviour of hydrogel beads as discussed earlier. 
Moreover, by increasing the amount of alginate content, volume fraction of alginate 
Figure 6. 
Effect of alginate/κ-carrageenan weight ratio’s on the swelling of the alginate/κ-carrageenan hydrogel beads 
with polymer concentrations (a) 1%, (b) 1.5%, (c) 2%, (d) 2.5%.
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in the hydrogel beads increases leading to the fact that curcumin molecules has to 
travel a long path in order to diffuse out through the swollen beads because of its 
characteristic size. This causes a slow release of curcumin from both the hydrogel 
beads.
4.3.2 Effect of κ-Car and gelatin on curcumin release
κ-Car content on drug release has been studied by varying κ-Car in the range 
20–50% (w/w). Figure 4 clearly depicts that the amount of released curcumin 
increases with increasing κ-Car content. With increase in κ-Car content in hydrogel 
beads, swelling increases resulting in enhanced drug release. Alginate/κ-Car beads 
with alginate/κ-Car weight ratio 50:50 showed highest curcumin release percentage 
(95.45%), owing to the fact that the matrices were built on weak entanglements 
driven by the presence of κ-Car.
4.3.3 Effect of gelatin on curcumin release
In the case of alginate/gelatin hydrogel beads, influence of gelatin content on 
curcumin release was studied by varying its amount in the range 20–50% (w/w) 
(Figure 7). Drug release investigations suggests that with increasing gelatin con-
tent, release of curcumin from alginate/gelatin hydrogel beads increases and the 
observed curcumin release is due to the larger swelling. Alginate/gelatin hydrogel 
beads with 50:50 weight ratios showed 48.24% curcumin release.
4.3.4  Effect of varying percentage composition of κ-Car and gelatin on  
curcumin release
Drug release from the hydrogel beads was also studied by varying polymer con-
centration in the range 1–2.5%. In the case of both hydrogel beads, 2.5% is the best 
Figure 7. 
Effect of alginate/gelatin weight ratio’s on cumulative release of curcumin from the hydrogel beads with 
polymer concentrations (a) 1%, (b) 1.5%, (c) 2%, (d) 2.5%.
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polymer concentration for curcumin release. Curcumin release from alginate/κ-Car 
hydrogel beads shows a higher release percentage than alginate/gelatin hydrogel 
beads. It can be concluded that higher swelling degree of the alginate/κ-Car hydro-
gel beads leads to greater curcumin release percentage.
5. Conclusions
Present study describes the development and evaluation of natural polymer 
based hydrogel beads for drug encapsulation. The key role of the carrier was for 
the dissolution of curcumin in aqueous media. Alginate/κ-Car hydrogel beads with 
50:50 weight ratio showed highest swelling degree having a higher of curcumin 
release percentage (95.45%) in PBS (pH 7.4). Observations of morphological analy-
sis show that the amount of carrageenan content has significant content in the pore 
size of beads. Swelling degree of alginate/gelatin hydrogel beads were lower than 
compared to the swelling behaviour of alginate/κ-Car hydrogel beads. This reveals 
the role of Car in improving the swelling as well as release pattern of curcumin. 
Results obtained reiterate the increased efficacy of polymer blends with incorpora-
tion of κ-Car for hydrophobic drug encapsulation. Effective drug release is also 
established. In fact, the drug release and biological activity of environment friendly 
hydrogel beads based on natural polymers represent an innovative and adequate 
alternative for the development of novel therapeutic agents in drug discovery 
research.
Acknowledgements
Authors acknowledge financial support from Kerala State Council for Science, 
Technology and Environment (SAN No. 564/2017/KSCSTE). We thank central 
instrumentation facility, Sacred Heart College for support and Cochin University of 
Science and Technology-STIC for instrumental analysis.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
12
Role of Novel Drug Delivery Vehicles in Nanobiomedicine
References
[1] Agarwal S, Mohamed MS, 
Raveendran S, Rochani AK, 
Maekawa T, Kumar DS. Formulation, 
characterization and evaluation 
of morusin loaded niosomes for 
potentiation of anticancer therapy. 
RSC Advances. 2018;8(57):32621-
32636. Available from: http://xlink.rsc.
org/?DOI=C8RA06362A
[2] Lim E-K, Chung B, Chung S. Recent 
advances in pH-sensitive polymeric 
nanoparticles for smart drug delivery in 
cancer therapy. Current Drug Targets.  
2016;17(999):1-1. Available 
from: http://www.eurekaselect.
com/openurl/content.
php?genre=article&doi=10.2174/ 
1389450117666160602202339
[3] Safari J, Zarnegar Z. Advanced drug 
delivery systems: Nanotechnology of 
health design a review. Journal of Saudi 
Chemical Society. 2014;18(2):85-99. 
DOI: 10.1016/j.jscs.2012.12.009
[4] John F, George J, Vartak SV, Srivastava 
M, Hassan PA, Aswal VK, et al. 
Enhanced efficacy of pluronic copolymer 
micelle encapsulated SCR7 against 
cancer cell proliferation. Macromolecular 
Bioscience. 2015;15(4):521-534
[5] Blanco E, Shen H, Ferrari 
M. Principles of nanoparticle design 
for overcoming biological barriers to 
drug delivery. Nature Biotechnology. 
2015;33(9):941-951
[6] Abedini F, Abraham J. Overview 
on natural hydrophilic polysaccharide 
polymers in drug delivery. Polymers 
Advanced Technologies. Wiley 
2017;2018:1-10
[7] John F, George J, Srivastava M, 
Hassan PA, Aswal VK, Karki S, et al. 
Pluronic copolymer encapsulated SCR7 
as a potential anticancer agent. Faraday 
Discussions. 2015;177:155-161. DOI: 
10.1039/C4FD00176A
[8] Parveen S, Misra R, Sahoo SK. 
Nanoparticles: A boon to drug delivery, 
therapeutics, diagnostics and imaging. 
Nanomedicine: Nanotechnology, Biology 
and Medicine. 2012;8(2):147-166. DOI: 
10.1016/j.nano.2011.05.016
[9] Arroyo E, Luque PA, Cosio M, Soto 
C, Villarreal R, Nava O, et al. Study 
of a controlled release polymeric 
system based on Pluronic P123: 
Spectroscopic characterization and 
theoretical model approach. Journal 
of Molecular Structure. 2017;1138:172-
176. DOI: 10.1016/j.molstruc.2017.03.018
[10] Senapati S. Controlled drug delivery 
vehicles for cancer treatment and their 
performance. Signal Transduction and 
Targeted Therapy 2017;2018:1-19
[11] Alippilakkotte S, Sreejith L. Pectin 
mediated synthesis of curcumin loaded 
poly(lactic acid) nanocapsules for cancer 
treatment. Journal of Drug Delivery 
Science and Technology. 2018;48:66-74. 
DOI: 10.1016/j.jddst.2018.09.001
[12] Zhao D, Zhao X, Zu Y, Li J, 
Zhang Y, Jiang R, et al. Preparation, 
characterization, and in vitro targeted 
delivery of folate-decorated paclitaxel-
loaded bovine serum albumin 
nanoparticles. International Journal of 
Nanomedicine. 2010;5(1):669-677
[13] Rosenblum D, Joshi N, Tao W,  
Karp JM, Peer D. Progress and 
challenges towards targeted delivery 
of cancer therapeutics. Nature 
Communications. 2018;9(1). DOI: 
10.1038/s41467-018-03705-y
[14] Sykes EA, Chen J, Zheng G, Chan 
WCW. Investigating the impact of 
nanoparticle size on active and passive 
tumor targeting efficiency. ACS Nano. 
2014;8(6):5696-5706
[15] Yingchoncharoen P, Kalinowski 
DS, Richardson DR. Lipid-based drug 
13
Preparation and Characterisation of Niosomal Emulsions as Novel Drug Delivery Vehicle…
DOI: http://dx.doi.org/10.5772/intechopen.86942
delivery systems in cancer therapy: 
What is available and what is yet to 
come. 2016;68:701-787
[16] Patra JK, Das G, Fraceto LF, Vangelie 
E, Campos R, Rodriguez P, et al. Nano 
based drug delivery systems: Recent 
developments and future prospects. 
Journal of Nanobiotechnology. 2018;16: 
1-33. DOI: 10.1186/s12951-018-0392-8
[17] Alshehri A, Grabowska A, Stolnik 
S. Pathways of cellular internalisation of 
liposomes delivered siRNA and effects 
on siRNA engagement with target 
mRNA and silencing in cancer cells. 
Scientific Reports. 2018;8(1):1-9
[18] Amjad MW, Kesharwani P, Mohd 
Amin MCI, Iyer AK. Recent advances 
in the design, development, and 
targeting mechanisms of polymeric 
micelles for delivery of siRNA in cancer 
therapy. Progress in Polymer Science. 
2017;64:154-181. DOI: 10.1016/j.
progpolymsci.2016.09.008
[19] Arora R, Kumar R, Agarwal A, 
Reeta KH, Gupta YK. Comparison of 
three different extracts of Centella 
asiatica for anti-amnesic, antioxidant 
and anticholinergic activities: in vitro 
and in vivo study. Biomedicine & 
Pharmacotherapy. 2018;105:1344-1352. 
DOI: 10.1016/j.biopha.2018.05.156
[20] Balakrishnan B, Jayakrishnan 
A. Self-cross-linking biopolymers 
as injectable in situ forming 
biodegradable scaffolds. Biomaterials. 
2005;26(18):3941-3951
[21] Gopinath V, Saravanan S, Al-maleki 
AR, Ramesh M, Vadivelu J. Biomedicine 
and pharmacotherapy: A review of 
natural polysaccharides for drug delivery 
applications: Special focus on cellulose, 
starch and glycogen. Biomedicine & 
Pharmacotherapy. 2018;107:96-108. 
DOI: 10.1016/j.biopha.2018.07.136
[22] Bartelds R, Nematollahi MH, Pols T, 
Stuart MCA, Pardakhty A, Asadikaram 
G, et al. Niosomes, an alternative 
for liposomal delivery. PLoS One. 
2018;13(4):1-18
[23] Moghassemi S, Hadjizadeh A. Nano-
niosomes as nanoscale drug delivery 
systems: An illustrated review. Journal 
of Controlled Release. 2014;185(1):22-
36. DOI: 10.1016/j.jconrel.2014.04.015
[24] Bhat PA, Chat OA, Zhang Y, Dar 
AA. An unprecedented dual responsive 
gelation of Carbopol induced by 
Pluronic P123 triblock copolymer. 
Polymer (Guildf). 2016;102:153-166. 
DOI: 10.1016/j.polymer.2016.09.013
[25] Bhattarai N, Gunn J, Zhang M. 
Chitosan-based hydrogels for controlled, 
localized drug delivery. Advanced Drug 
Delivery Reviews. 2010;62(1):83-99. 
DOI: 10.1016/j.addr.2009.07.019
[26] Mészáros M, Porkoláb G, Kiss L, 
Pilbat AM, Kóta Z, Kupihár Z, et al. 
Niosomes decorated with dual ligands 
targeting brain endothelial transporters 
increase cargo penetration across 
the blood-brain barrier. European 
Journal of Pharmaceutical Sciences. 
2018;123:228-240. DOI: 10.1016/j.
ejps.2018.07.042
[27] Elzoghby AO, Freag MS, Elkhodairy 
KA. Biopolymeric nanoparticles 
for targeted drug delivery to brain 
tumors. In: Kesharwani P, Gupta 
U editor. Nanotechnology-Based 
Targeted Drug Delivery Systems for 
Brain Tumors. Elsevier Inc.; 24 Apr 
2018. pp. 169-190. Available from: 
https://linkinghub.elsevier.com/
retrieve/pii/B9780128122181000075. 
ISBN: 9780128122181. eBook ISBN: 
9780128122495
[28] Gao N, Lü S, Gao C, Wang X, Xu X, 
Bai X, et al. Injectable shell-crosslinked 
F127 micelle/hydrogel composites with 
pH and redox sensitivity for combined 
release of anticancer drugs. Chemical 
Engineering Journal. 2016;287:20-29. 
DOI: 10.1016/j.cej.2015.11.015
Role of Novel Drug Delivery Vehicles in Nanobiomedicine
14
[29] Gianak O, Pavlidou E, Sarafidis C, 
Karageorgiou V, Deliyanni E. Silk fibroin 
nanoparticles for drug delivery: Effect 
of bovine serum albumin and magnetic 
nanoparticles addition on drug 
encapsulation and release. Separations. 
2018;5(2):25. Available from: http://
www.mdpi.com/2297-8739/5/2/25
[30] Hyun H, Park J, Willis K, Park 
JE, Lyle LT, Lee W, et al. Surface 
modification of polymer nanoparticles 
with native albumin for enhancing drug 
delivery to solid tumors. Biomaterials. 
2018;180:206-224. DOI: 10.1016/j.
biomaterials.2018.07.024
[31] Liang H, He L, Zhou B, Li B, Li 
J. Folate-functionalized assembly 
of low density lipoprotein/sodium 
carboxymethyl cellulose nanoparticles 
for targeted delivery. Colloids and 
Surfaces. B, Biointerfaces. 2017;156:19-
28. DOI: 10.1016/j.colsurfb.2017.05.004
[32] Marianecci C, Di Marzio L, Rinaldi 
F, Celia C, Paolino D, Alhaique F, et al. 
Niosomes from 80s to present: The state 
of the art. Advances in Colloid and 
Interface Science. 2014;205:187-206. 
DOI: 10.1016/j.cis.2013.11.018
[33] Qin Y, Tian Y, Liu Y, Li D, Zhang 
H, Yang Y, et al. Hyaluronic acid-
modified cationic niosomes for ocular 
gene delivery: Improving transfection 
efficiency in retinal pigment epithelium. 
The Journal of Pharmacy and 
Pharmacology. 2018;70(9):1139-1151
[34] Rajera R, Nagpal K, Singh SK, 
Mishra DN. Niosomes: A controlled 
and novel drug delivery system. 
Biological & Pharmaceutical Bulletin. 
2011;34(7):945-953. Available from: 
https://www.jstage.jst.go.jp/article/
bpb/34/7/34_7_945/_article
[35] Gu D, O’Connor AJ, Qiao GGH, 
Ladewig K. Hydrogels with smart 
systems for delivery of hydrophobic 
drugs. Expert Opinion on Drug 
Delivery. 2017;14(7):879-895. DOI: 
10.1080/17425247.2017.1245290
[36] Blount RP, Bhattarai N. Natural 
Polysaccharide-Based Hydrogels 
for Controlled Localized Drug 
Delivery. Gels Handbook. 2016;35-59. 
DOI:10.1142/9789813140417_0002 
[37] Chen J, Huang GD, Tan SR, Guo J, 
Su ZQ. The preparation of capsaicin-
chitosan microspheres (CCMS) 
enteric coated tablets. International 
Journal of Molecular Sciences. 
2013;14(12):24305-24319
[38] Liu Z, Jiao Y, Wang Y, Zhou C, Zhang 
Z. Polysaccharides-based nanoparticles 
as drug delivery systems. Advanced Drug 
Delivery Reviews. 2008;60(15):1650-
1662. DOI: 10.1016/j.addr.2008.09.001
[39] Sathuvan M, Thangam R, Gajendiran 
M, Vivek R, Balasubramanian S, Nagaraj 
S, et al. κ-Carrageenan: An effective 
drug carrier to deliver Curcumin in 
cancer cells and to induce apoptosis. 
Carbohydrate Polymers. 2016;160:184-
193 DOI: 10.1016/j.carbpol.2016.12.049
[40] Malafaya PB, Silva GA, Reis 
RL. Natural-origin polymers as carriers 
and scaffolds for biomolecules and 
cell delivery in tissue engineering 
applications. Advanced Drug Delivery 
Reviews.Elsevier 2007;59:207-233
[41] Yadav G, Sharma N, Bansal 
M. Thakur N, Application of natural 
polysaccharide for delivery of 
biopharmaceuticals. International 
Journal of pharmacy & Life Sciences. 
2013;4(6):2756-2765
[42] Boateng J, Burgos-Amador R, 
Okeke O, Pawar H. Composite alginate 
and gelatin based bio-polymeric 
wafers containing silver sulfadiazine 
for wound healing. International 
Journal of Biological Macromolecules. 
2015;79:63-71. DOI: 10.1016/j.
ijbiomac.2015.04.048
[43] Shimizu T, Yamato M, Kikuchi A,  
Okano T. Cell sheet engineering for 
myocardial tissue reconstruction. In: 
Leong K editor. The Biomaterials: Silver 
15
Preparation and Characterisation of Niosomal Emulsions as Novel Drug Delivery Vehicle…
DOI: http://dx.doi.org/10.5772/intechopen.86942
Jubilee Compendium. Vol. 24. Elsevier. 
2006. pp. 211-218. ISSN: 0142-9612
[44] Pankongadisak P, Ruktanonchai 
UR, Supaphol P, Suwantong O. 
Development of silver nanoparticles-
loaded calcium alginate beads 
embedded in gelatin scaffolds for 
use as wound dressings. Polymer 
International. 2015;64(2):275-283
[45] Cuadros TR, Erices AA, Aguilera 
JM. Porous matrix of calcium alginate/
gelatin with enhanced properties as 
scaffold for cell culture. Journal of the 
Mechanical Behavior of Biomedical 
Materials. 2015;46:331-342
[46] John F, George JUK. Curcumin 
encapsulated alginate/Pluronic block 
copolymer micelles as a promising 
therapeutic agent. UK Journal of 
Pharmaceutical and Biosciences. 
2014;2(3):6-12. Available from: www.
ukjpb.com
[47] Mei L, He F, Zhou RQ , De 
Wu C, Liang R, Xie R, et al. Novel 
intestinal-targeted Ca-alginate-based 
carrier for pH-responsive protection 
and release of lactic acid bacteria. 
ACS Applied Materials & Interfaces. 
2014;6(8):5962-5970
[48] Santoro M, Tatara AM, Mikos 
AG. Gelatin carriers for drug and cell 
delivery in tissue engineering. Journal of 
Controlled Release. 2014;190:210-218. 
DOI: 10.1016/j.jconrel.2014.04.014
[49] Ganta S, Devalapally H, Shahiwala 
A, Amiji M. A review of stimuli-
responsive nanocarriers for drug and 
gene delivery. Journal of Controlled 
Release. 2008;126(3):187-204
[50] Lázaro N, López Sevilla A, 
Morales S, Marqués AM. Heavy metal 
biosorption by gellan gum gel beads. 
Water Research. 2003;37(9):2118-2126
